People · Operator
Named in public records as an officer, director or promoter · active 2022–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TuHURA Biosciences, Inc./NV | — | Biotechnology | Series B | $41.6M | $6.1M | 2025 |
| Morphogenesis Inc | — | Biotechnology | Series B | $27.9M | $15.1M | 2022 |
Dan Dearborn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dan Dearborn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Manuso | 2 | 4 |
| James Bianco | 2 | 4 |
| George Ng | 2 | 4 |
| Alan List | 2 | 2 |
| Robert Hoffman | 1 | 5 |
| Dennis Brown | 1 | 5 |
| Keith Murphy | 1 | 4 |
| SAIID ZARRABIAN | 1 | 3 |
| WILLIAM GARNER | 1 | 2 |
| John K. Bell | 1 | 2 |
| Jeffrey Bacha | 1 | 2 |
| Laura Johnson | 1 | 2 |
| Craig Tendler | 1 | 1 |
| Lisa Guise | 1 | 1 |
| Erich K Mohr | 1 | 1 |
| John Liatos | 1 | 1 |
| Lynda Cranston | 1 | 1 |
| Steven Rychnovsky | 1 | 1 |
| Robert K Toth | 1 | 1 |
| Scott Praill | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.